INTRODUCTION: Epicardial adipose tissue (EAT) is the true visceral fat depot of the heart. The relationship between coronary artery disease and EAT was shown in end-stage renal disease (ESRD) patients. One of the established risk factor in this population is dyslipidemia. We aimed to determine the relationship between atherogenic index of plasma (AIP) and EAT in ESRD patients. METHODS: This was a cross-sectional study involving 76 ESRD patients receiving PD or HD for ≥6 months and 42 healthy subjects. EAT was measured by using an electrocardiogram-gated 64-multidetector computed tomography (MDCT). Atherogenic index of plasma was calculated as the logarithmically transformed ratio of the serum trigliseride to HDL-cholesterol. RESULTS: The etiology of ESRD patients was diabetic nephropathy (n = 16), chronic glomerulonephritis (n = 10), hypertensive nephropathy (n = 23), polycystic kidney disease (n = 7), nephrolithiasis (n = 5) and unknown (n = 15). There were no differences with respect to the following variables between ESRD patients and healthy subjects: age; sex; BMI; predialysis levels of DBP; serum levels of albumin, HDL-cholesterol and hemoglobin. However, ESRD patients had higher serum levels of trigliseride, hs-CRP and AIP when compared to healthy subjects. There was a statistically significant relationship between EAT, BMI and AIP in ESRD patients (r = 0.42, p < 0.001 and r = 0.25, p = 0.028, respectively). The stepwise linear regression analysis revealed that age, as well as BMI were independent predictors of EAT. CONCLUSION: We found a relationship between EAT as defined by MDCT and AIP in ESRD patients. Further clinical and experimental studies are needed.
INTRODUCTION: Epicardial adipose tissue (EAT) is the true visceral fat depot of the heart. The relationship between coronary artery disease and EAT was shown in end-stage renal disease (ESRD) patients. One of the established risk factor in this population is dyslipidemia. We aimed to determine the relationship between atherogenic index of plasma (AIP) and EAT in ESRDpatients. METHODS: This was a cross-sectional study involving 76 ESRDpatients receiving PD or HD for ≥6 months and 42 healthy subjects. EAT was measured by using an electrocardiogram-gated 64-multidetector computed tomography (MDCT). Atherogenic index of plasma was calculated as the logarithmically transformed ratio of the serum trigliseride to HDL-cholesterol. RESULTS: The etiology of ESRDpatients was diabetic nephropathy (n = 16), chronic glomerulonephritis (n = 10), hypertensive nephropathy (n = 23), polycystic kidney disease (n = 7), nephrolithiasis (n = 5) and unknown (n = 15). There were no differences with respect to the following variables between ESRDpatients and healthy subjects: age; sex; BMI; predialysis levels of DBP; serum levels of albumin, HDL-cholesterol and hemoglobin. However, ESRDpatients had higher serum levels of trigliseride, hs-CRP and AIP when compared to healthy subjects. There was a statistically significant relationship between EAT, BMI and AIP in ESRDpatients (r = 0.42, p < 0.001 and r = 0.25, p = 0.028, respectively). The stepwise linear regression analysis revealed that age, as well as BMI were independent predictors of EAT. CONCLUSION: We found a relationship between EAT as defined by MDCT and AIP in ESRDpatients. Further clinical and experimental studies are needed.
Authors: Emin Murat Akbas; Levent Demirtas; Adalet Ozcicek; Aysu Timuroglu; Eftal Murat Bakirci; Hikmet Hamur; Fatih Ozcicek; Kultigin Turkmen Journal: Int J Clin Exp Med Date: 2014-07-15
Authors: Sean Cai; Ron Wald; Djeven P Deva; Mercedeh Kiaii; Ming-Yen Ng; Gauri R Karur; Oblugbenga Bello; Zhuo Jun Li; Jonathon Leipsic; Laura Jimenez-Juan; Anish Kirpalani; Kim A Connelly; Andrew T Yan Journal: J Nephrol Date: 2019-11-14 Impact factor: 3.902
Authors: Jeremy Yuvaraj; Mourushi Isa; Zhu Chung Che; Egynne Lim; Nitesh Nerlekar; Stephen J Nicholls; Sujith Seneviratne; Andrew Lin; Damini Dey; Dennis T L Wong Journal: Sci Rep Date: 2022-06-10 Impact factor: 4.996
Authors: Emin Murat Akbas; Adem Gungor; Adalet Ozcicek; Nergis Akbas; Seda Askin; Murat Polat Journal: Arch Med Sci Date: 2016-07-01 Impact factor: 3.318
Authors: Danijela Ristovski-Kornic; Aleksandra Stefanović; Jelena Kotur-Stevuljević; Aleksandra Zeljković; Vesna Spasojević-Kalimanovska; Jelena Vekić; Milica Miljković; Dušan Paripović; Amira Peco-Antić; Zorana Jelić-Ivanović Journal: J Med Biochem Date: 2017-01-25 Impact factor: 3.402
Authors: Zülfükar Yilmaz; Hasan İnce; Emre Aydin; Yasar Yildirim; Fatma Yilmaz Aydin; Enver Yüksel; Aziz Karabulut; Lezgin Dursun; Ali Kemal Kadiroğlu; Mehmet Emin Yilmaz Journal: Med Sci Monit Date: 2020-02-07